AES
47
4
ABBV
40
5
WMT
68
-2
CMA
42
3
CCL
68
6
GWW
50
9
ADBE
50
3
EIX
61
8
PPL
44
9
PSX
24
2
HPQ
55
3
EQIX
59
2
MMC
46
5
DVA
62
5
BAX
38
2
CAH
44
7
EMC
30
-26
TXT
46
4
BDX
59
3
DNB
72
4
AES
47
4
ABBV
40
5
WMT
68
-2
CMA
42
3
CCL
68
6
GWW
50
9
ADBE
50
3
EIX
61
8
PPL
44
9
PSX
24
2
HPQ
55
3
EQIX
59
2
MMC
46
5
DVA
62
5
BAX
38
2
CAH
44
7
EMC
30
-26
TXT
46
4
BDX
59
3
DNB
72
4
Financhill
Back

Poseida Therapeutics 10K Form

Sell
48

PSTX
Poseida Therapeutics

Last Price:
$9.47
Seasonality Move:
-14.94%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PSTX News And Ratings

See the #1 stock for the next 7 days that we like better than PSTX

PSTX Financial Statistics

Sales & Book Value

Annual Sales: $64.7M
Cash Flow: $-10.2M
Price / Cash Flow: 1229.95
Annual Sales: $0.90
Price / Book: 10.58

Profitability

EPS (TTM): -0.62000
Net Income (TTM): $-60.8M
Gross Margin: --
Return on Equity: -66.05%
Return on Assets: -21.23%

Poseida Therapeutics Earnings Forecast

Key Poseida Therapeutics Financial Ratios

  • The Research & Development expenses have been 242.29% of Revenue.
  • The Interest Expense is -7.03% of Operating Income.
  • The Net Earning history of PSTX is -190.76% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 2 years.

Poseida Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: PSTX
CUSIP: 73730P
Website: poseida.com

Debt

Debt-to-Equity Ratio: 0.68
Current Ratio: 3.2
Quick Ratio: 3.14

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PSTX Technical Analysis vs Fundamental Analysis

Sell
48
Poseida Therapeutics (PSTX) is a Sell

Is Poseida Therapeutics a Buy or a Sell?